香港股市 已收市

ORIC Pharmaceuticals, Inc. (ORIC)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
13.47+0.01 (+0.04%)
收市:04:00PM EDT
13.46 -0.00 (-0.01%)
收市後: 04:02PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價13.46
開市13.54
買盤13.39 x 100
賣出價13.50 x 100
今日波幅13.28 - 13.88
52 週波幅4.89 - 16.65
成交量389,576
平均成交量558,185
市值907.215M
Beta 值 (5 年,每月)1.03
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-1.96
業績公佈日2024年5月06日 - 2024年5月10日
遠期股息及收益率無 (無)
除息日
1 年預測目標價19.14
  • Zacks

    How Much Upside is Left in Oric Pharmaceuticals (ORIC)? Wall Street Analysts Think 39.3%

    The mean of analysts' price targets for Oric Pharmaceuticals (ORIC) points to a 39.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

  • Zacks

    Recent Price Trend in Oric Pharmaceuticals, Inc. (ORIC) is Your Friend, Here's Why

    Oric Pharmaceuticals, Inc. (ORIC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

  • InvestorPlace

    Final Boarding Call: 3 Stocks Set for a Sky-High Surge

    Under most financial guidance frameworks, experts advise a long-term approach, which is exactly the opposite ethos when it comes to speculative ideas for high potential stocks. Here, the emphasis centers on getting in, scalping a quick profit and getting out to advantage the next opportunity. To better determine stocks ready to soar, I primarily looked at Fintel’s Short Squeeze Leaderboard. But rather than relying on its proprietary rankings, I decided to look at the combination of short interes